Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LISINOPRIL, with a corresponding US DMF Number 16510.
Remarkably, this DMF maintains an Active status since its submission on March 21, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 11, 2012, and payment made on November 29, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II